To determine the proportion of subjects with undetectable plasma HIV RNA, by treatment and baseline RNA cohort; to determine the durability of these regimens by estimating the distribution of time to loss of virologic suppression, by treatment and baseline RNA cohort.
Showing the most recent 10 out of 642 publications